{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:58:21Z","timestamp":1791197901572,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["D43TW009340"],"award-info":[{"award-number":["D43TW009340"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA250850"],"award-info":[{"award-number":["R01CA250850"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21TW011715"],"award-info":[{"award-number":["R21TW011715"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ogc.2022.08.008","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T17:07:56Z","timestamp":1667236076000},"page":"771-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prevention of Cervical Cancer in Low-Resource African Settings"],"prefix":"10.1016","volume":"49","author":[{"given":"Masangu","family":"Mulongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-2994","authenticated-orcid":false,"given":"Carla J.","family":"Chibwesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ogc.2022.08.008_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.ogc.2022.08.008_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ogc.2022.08.008_bib5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1245\/s10434-014-4344-8","article-title":"Control of cancer of the cervix in low- and middle-income countries","volume":"22","author":"Denny","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ogc.2022.08.008_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.aogh.2014.09.014","article-title":"Screening for cancer in low- and middle-income countries","volume":"80","author":"Sankaranarayanan","year":"2014","journal-title":"Ann Glob Health"},{"issue":"3","key":"10.1016\/j.ogc.2022.08.008_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijgo.12656","article-title":"Making HPV vaccination available to girls everywhere","volume":"143","author":"Oberlin","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.ogc.2022.08.008_bib8","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","article-title":"Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities","volume":"5","author":"Gakidou","year":"2008","journal-title":"Plos Med"},{"issue":"2","key":"10.1016\/j.ogc.2022.08.008_bib10","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"50","key":"10.1016\/j.ogc.2022.08.008_bib11","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1016\/j.vaccine.2010.08.090","article-title":"Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa","volume":"28","author":"Francis","year":"2010","journal-title":"Vaccine"},{"issue":"2 Suppl","key":"10.1016\/j.ogc.2022.08.008_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1757975910363938","article-title":"Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators","volume":"17","author":"Chirwa","year":"2010","journal-title":"Glob Health Promot"},{"key":"10.1016\/j.ogc.2022.08.008_bib13","article-title":"Barriers and Facilitators to Cervical Cancer Screening in Western Kenya: a Qualitative Study","author":"Adewumi","year":"2021","journal-title":"J\u00a0Cancer Educ"},{"key":"10.1016\/j.ogc.2022.08.008_bib14","author":"World Health Organization"},{"issue":"11","key":"10.1016\/j.ogc.2022.08.008_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group","volume":"87","author":"Bosch","year":"1995","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ogc.2022.08.008_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J\u00a0Pathol"},{"issue":"9895","key":"10.1016\/j.ogc.2022.08.008_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"issue":"43","key":"10.1016\/j.ogc.2022.08.008_bib18","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"issue":"3 Suppl 2","key":"10.1016\/j.ogc.2022.08.008_bib19","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","article-title":"Natural history and epidemiology of HPV infection and cervical cancer","volume":"110","author":"Castellsague","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.ogc.2022.08.008_bib20","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.ogc.2022.08.008_bib21","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ogc.2022.08.008_bib22","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/AOG.0b013e3181743327","article-title":"Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women","volume":"111","author":"Denny","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.ogc.2022.08.008_bib23","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1086\/599123","article-title":"Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women","volume":"199","author":"Singh","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.ogc.2022.08.008_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bpobgyn.2004.10.002","article-title":"HIV and cancer of the cervix","volume":"19","author":"Chirenje","year":"2005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ogc.2022.08.008_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/CCO.0b013e32833cff4f","article-title":"Issues in cervical cancer incidence and treatment in HIV","volume":"22","author":"Einstein","year":"2010","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"10.1016\/j.ogc.2022.08.008_bib26","first-page":"505","article-title":"Cervical cancer prevention and control in women living with human immunodeficiency virus","volume":"71","author":"Castle","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ogc.2022.08.008_bib27","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/520022","article-title":"Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy","volume":"45","author":"Franceschi","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ogc.2022.08.008_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnci\/djr235","article-title":"AIDS-related cancers increase in Africa","volume":"103","author":"Brower","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2022.08.008_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-med-050409-103711","article-title":"The increasing burden of HIV-associated malignancies in resource-limited regions","volume":"62","author":"Casper","year":"2011","journal-title":"Annu Rev Med"},{"issue":"9576","key":"10.1016\/j.ogc.2022.08.008_bib31","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in\u00a0situ: a combined analysis of four randomised clinical trials","volume":"369","author":"Ault","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ogc.2022.08.008_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ogc.2022.08.008_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A\u00a09-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2022.08.008_bib34","author":"World Health Organization"},{"issue":"2","key":"10.1016\/j.ogc.2022.08.008_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.31321","article-title":"Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14-year-old girls against human papillomavirus","volume":"143","author":"Jit","year":"2018","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.ogc.2022.08.008_bib36","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2214-109X(14)70237-2","article-title":"Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study","volume":"2","author":"Jit","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"10033","key":"10.1016\/j.ogc.2022.08.008_bib37","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(15)00755-2","article-title":"Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition","volume":"387","author":"Gelband","year":"2016","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2022.08.008_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ijgo.13879","article-title":"Worldwide initiatives to eliminate cervical cancer","volume":"155","author":"Wilailak","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.ogc.2022.08.008_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.mcna.2017.03.006","article-title":"Cervical Cancer Screening","volume":"101","author":"Sawaya","year":"2017","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.ogc.2022.08.008_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"16","author":"Saslow","year":"2012","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"1","key":"10.1016\/j.ogc.2022.08.008_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/COH.0b013e328319bcbe","article-title":"Prevention of cervical cancer in women with HIV","volume":"4","author":"Heard","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"issue":"10","key":"10.1016\/j.ogc.2022.08.008_bib42","doi-asserted-by":"crossref","first-page":"e78411","DOI":"10.1371\/journal.pone.0078411","article-title":"Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya","volume":"8","author":"Maranga","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ogc.2022.08.008_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41568-021-00396-4","article-title":"Removing global barriers to cervical cancer prevention and moving towards elimination","volume":"21","author":"Alfaro","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 5","key":"10.1016\/j.ogc.2022.08.008_bib44","doi-asserted-by":"crossref","first-page":"F47","DOI":"10.1016\/j.vaccine.2012.06.066","article-title":"Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa","volume":"31","author":"Sankaranarayanan","year":"2013","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ogc.2022.08.008_bib45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2217\/hiv.10.52","article-title":"Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness","volume":"4","author":"Parham","year":"2010","journal-title":"HIV Ther"},{"issue":"4","key":"10.1016\/j.ogc.2022.08.008_bib46","doi-asserted-by":"crossref","first-page":"e0122169","DOI":"10.1371\/journal.pone.0122169","article-title":"Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia","volume":"10","author":"Parham","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ogc.2022.08.008_bib47","author":"World Health Organization"},{"issue":"6","key":"10.1016\/j.ogc.2022.08.008_bib48","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ijc.20190","article-title":"Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa","volume":"110","author":"Sankaranarayanan","year":"2004","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ogc.2022.08.008_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.23489","article-title":"Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India","volume":"123","author":"Arbyn","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2022.08.008_bib50","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1200\/GO.21.00168","article-title":"Accuracy of Smartphone Images of the Cervix After Acetic Acid Application for Diagnosing Cervical Intraepithelial Neoplasia Grade 2 or Greater in Women With Positive Cervical Screening: A Systematic Review and Meta-Analysis","volume":"7","author":"Allanson","year":"2021","journal-title":"JCO Glob Oncol"},{"issue":"4","key":"10.1016\/j.ogc.2022.08.008_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ijc.21050","article-title":"A\u00a0cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India","volume":"116","author":"Sankaranarayanan","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2022.08.008_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ypmed.2016.12.030","article-title":"The time is now to implement HPV testing for primary screening in low resource settings","volume":"98","author":"Kuhn","year":"2017","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.ogc.2022.08.008_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrclinonc.2015.146","article-title":"HPV-FASTER: broadening the scope for prevention of HPV-related cancer","volume":"13","author":"Bosch","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"9916","key":"10.1016\/j.ogc.2022.08.008_bib54","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ogc.2022.08.008_bib55","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12916-021-02026-0","article-title":"Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study","volume":"19","author":"Zhao","year":"2021","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.ogc.2022.08.008_bib56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12916-019-1460-0","article-title":"Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study","volume":"17","author":"Aitken","year":"2019","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.ogc.2022.08.008_bib57","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/ijc.29530","article-title":"Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina","volume":"137","author":"Arrossi","year":"2015","journal-title":"Int J Cancer"},{"issue":"17","key":"10.1016\/j.ogc.2022.08.008_bib58","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1001\/jama.294.17.2173","article-title":"Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial","volume":"294","author":"Denny","year":"2005","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ogc.2022.08.008_bib59","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1097\/QAD.0b013e32833e163e","article-title":"Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women","volume":"24","author":"Kuhn","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.ogc.2022.08.008_bib60","author":"World Health Organization"},{"issue":"5","key":"10.1016\/j.ogc.2022.08.008_bib61","first-page":"635","article-title":"Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline","volume":"3","author":"Jeronimo","year":"2017","journal-title":"J\u00a0Glob Oncol"},{"issue":"8","key":"10.1016\/j.ogc.2022.08.008_bib63","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","article-title":"2020 list of human papillomavirus assays suitable for primary cervical cancer screening","volume":"27","author":"Arbyn","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ogc.2022.08.008_bib64","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/IGC.0000000000000084","article-title":"A\u00a0multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer","volume":"24","author":"Jeronimo","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ogc.2022.08.008_bib65","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/JCM.00176-14","article-title":"Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy","volume":"52","author":"Einstein","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ogc.2022.08.008_bib66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13027-020-00328-1","article-title":"Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening","volume":"15","author":"Zhang","year":"2020","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.ogc.2022.08.008_bib67","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ogc.2022.08.008_bib68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","article-title":"The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis","volume":"93","author":"Nelson","year":"2017","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ogc.2022.08.008_bib69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fpubh.2018.00077","article-title":"Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs","volume":"6","author":"Gupta","year":"2018","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.ogc.2022.08.008_bib70","doi-asserted-by":"crossref","first-page":"e001351","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis","volume":"4","author":"Yeh","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ogc.2022.08.008_bib71","author":"Unitaid"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854522000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854522000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:26:14Z","timestamp":1760178374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854522000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0889854522000675"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2022.08.008","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Cervical Cancer in Low-Resource African Settings","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2022.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}